President Donald Trump signed an executive order that could make it easier for scientists to study cannabis for medical use.

The FDA is weighing a change that could make warning labels on dietary supplements appear less often on packaging.

The FDA approved Lerochol, a monthly PCSK9 inhibitor, for adults with hypercholesterolemia to reduce LDL-C levels alongside diet and exercise.

Traditional Chinese medicine (TCM) pediatric tuina may be safe and effective as supplementary therapy in children with severe pneumonia.

FDA approves Rybrevant Faspro, a subcutaneous amivantamab formulation, for all indications previously held by the intravenous formulation.

The HHS has ended several health grants to one of the nation’s largest pediatricians’ groups, a move the organization says could hurt children and families.

Influenza season is getting an early start in New York City, with doctors reporting a sharp jump in cases weeks sooner than normal.

Men and women with emphysema benefit from endoscopic lung volume reduction (ELVR), but women may have better symptom response and QoL.

About 9% of patients with inborn errors of immunity/primary immune disorders developed cancer, especially B-NHL, a European study found.

President Donald Trump has signed an executive order declaring the street drug fentanyl a weapon of mass destruction.

Use of inhaled corticosteroids by pregnant mothers with asthma may protect infants against reduced lung function at 4 to 6 weeks of age.

Early termination of the 6-minute walk test may be a practical and prognostic marker for severe adverse events in patients with COPD.